Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
487 hedge funds and large institutions have $13.1B invested in Abiomed Inc in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 160 increasing their positions, 192 reducing their positions, and 59 closing their positions.
59% more call options, than puts
Call options by funds: $104M | Put options by funds: $65.7M
2% less funds holding
Funds holding: 498 → 487 (-11)
5% less capital invested
Capital invested by funds: $13.9B → $13.1B (-$726M)
12% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 59
17% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 192
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$128M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$119M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$69.3M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$42.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sands Capital Management
Arlington,
Virginia
|
-$480M |
| 2 |
FAM
Fred Alger Management
New York
|
-$162M |
| 3 |
Renaissance Technologies
New York
|
-$68.4M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
-$59.6M |
| 5 |
Primecap Management
Pasadena,
California
|
-$41.5M |
ABMD Hedge Fund Activity: Q1 2021 in Review
487 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2021, worth a combined $13.1B — down 5.2% from $13.9B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of ABMD and 52 opened new positions — a net loss of 7 holders — while 192 trimmed existing stakes and 160 added.
The largest buyer was Baillie Gifford & Co, adding an estimated $128M. The largest seller was Sands Capital Management, exiting entirely with an estimated $480M sold.
- 487 institutional investors held Abiomed Inc (ABMD) as of Q1 2021, down from 498 in Q4 2020.
- Funds reported $13.1B of Abiomed Inc stock for Q1 2021, down 5.2% quarter-over-quarter.
- 52 funds opened new Abiomed Inc positions in Q1 2021 and 59 closed out, a net change of -7 holders.
- The largest Abiomed Inc buyer in Q1 2021 was Baillie Gifford & Co, an estimated $128M added.
- The largest Abiomed Inc seller in Q1 2021 was Sands Capital Management, an estimated $480M sold.
Based on aggregated 13F filings for Q1 2021.